Literature DB >> 25062674

Cardiac Dysautonomia in Huntington's Disease.

Mads Abildtrup1, Michael Shattock2.   

Abstract

Huntington's disease is a fatal, hereditary, neurodegenerative disorder best known for its clinical triad of progressive motor impairment, cognitive deficits and psychiatric disturbances. Although a disease of the central nervous system, mortality surveys indicate that heart disease is a leading cause of death. The nature of such cardiac abnormalities remains unknown. Clinical findings indicate a high prevalence of autonomic nervous system dysfunction - dysautonomia - which may be a result of pathology of the central autonomic network. Dysautonomia can have profound effects on cardiac health, and pronounced autonomic dysfunction can be associated with neurogenic arrhythmias and sudden cardiac death. Significant advances in the knowledge of neural mechanisms in cardiac disease have recently been made which further aid our understanding of cardiac mortality in Huntington's disease. Even so, despite the evidence of aberrant autonomic activity the potential cardiac consequences of autonomic dysfunction have been somewhat ignored. In fact, underlying cardiac abnormalities such as arrhythmias have been part of the exclusion criteria in clinical autonomic Huntington's disease research. A comprehensive analysis of cardiac function in Huntington's disease patients is warranted. Further experimental and clinical studies are needed to clarify how the autonomic nervous system is controlled and regulated in higher, central areas of the brain - and how these regions may be altered in neurological pathology, such as Huntington's disease. Ultimately, research will hopefully result in an improvement of management with the aim of preventing early death in Huntington's disease from cardiac causes.

Entities:  

Keywords:  BDNF; Huntington's disease; arrhythmias; cardiac death; dysautonomia; heart disease; heart rate variability

Mesh:

Year:  2013        PMID: 25062674     DOI: 10.3233/JHD-130054

Source DB:  PubMed          Journal:  J Huntingtons Dis        ISSN: 1879-6397


  19 in total

1.  Progressive cardiac arrhythmias and ECG abnormalities in the Huntington's disease BACHD mouse model.

Authors:  Yujie Zhu; Isaac Shamblin; Efrain Rodriguez; Grace E Salzer; Lita Araysi; Katherine A Margolies; Ganesh V Halade; Silvio H Litovsky; Steven Pogwizd; Michelle Gray; Sabine Huke
Journal:  Hum Mol Genet       Date:  2020-02-01       Impact factor: 6.150

2.  Huntington's Disease-Induced Cardiac Disorders Affect Multiple Cellular Pathways.

Authors:  Girish C Melkani
Journal:  React Oxyg Species (Apex)       Date:  2016-09

Review 3.  Cardiac Involvement in Movement Disorders.

Authors:  Malco Rossi; Nestor Wainsztein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2021-04-07

4.  Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes.

Authors:  Laureen Jacquet; Andreas Neueder; Gabor Földes; Panagiotis Karagiannis; Carl Hobbs; Nelly Jolinon; Maxime Mioulane; Takao Sakai; Sian E Harding; Dusko Ilic
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

5.  Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington's disease transgenic R6/2 (160 CAG) mice.

Authors:  A Di Pardo; A Carrizzo; A Damato; S Castaldo; E Amico; L Capocci; M Ambrosio; F Pompeo; C De Sanctis; C C Spinelli; A A Puca; P Remondelli; V Maglione; C Vecchione
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

6.  Neurocardiovascular deficits in the Q175 mouse model of Huntington's disease.

Authors:  Tamara S Cutler; Saemi Park; Dawn H Loh; Maria C Jordan; Tomohiro Yokota; Kenneth P Roos; Cristina A Ghiani; Christopher S Colwell
Journal:  Physiol Rep       Date:  2017-06

7.  Electrocardiogram Abnormalities Suggest Aberrant Cardiac Conduction in Huntington's Disease.

Authors:  Christopher D Stephen; Judy Hung; Giovanni Schifitto; Steven M Hersch; H Diana Rosas
Journal:  Mov Disord Clin Pract       Date:  2018-04-11

8.  Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samples.

Authors:  Anastasios Mastrokolias; Rene Pool; Eleni Mina; Kristina M Hettne; Erik van Duijn; Roos C van der Mast; GertJan van Ommen; Peter A C 't Hoen; Cornelia Prehn; Jerzy Adamski; Willeke van Roon-Mom
Journal:  Metabolomics       Date:  2016-07-27       Impact factor: 4.290

9.  Cardiac mTORC1 Dysregulation Impacts Stress Adaptation and Survival in Huntington's Disease.

Authors:  Daniel D Child; John H Lee; Christine J Pascua; Yong Hong Chen; Alejandro Mas Monteys; Beverly L Davidson
Journal:  Cell Rep       Date:  2018-04-24       Impact factor: 9.423

10.  Overlap between age-at-onset and disease-progression determinants in Huntington disease.

Authors:  N Ahmad Aziz; Jorien M M van der Burg; Sarah J Tabrizi; G Bernhard Landwehrmeyer
Journal:  Neurology       Date:  2018-05-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.